Further evaluation of the microhaemagglutination test to determine treponemal antibodies in CSF.
AUTOR(ES)
Kasatiya, S
RESUMO
The results of a microhaemagglutination test (MHA:TP) using diluted (MHA:TP-DCSF) and undiluted (MHA:TP-UCSF) samples of cerebrospinal fluid (CSF) from 1452 patients with syphilis, neurological, metabolic, or immunological disorders, and undetermined diagnoses to detect antitreponemal antibodies were compared with those of the Venereal Disease Research Laboratory (VDRL-CSF) test and the fluorescent treponemal antibody (FTA-CSF) test. Using undiluted samples of CSF the MHA:TP test gave more reactive results than with diluted samples. The MHA:TP-UCSF test was slightly more specific and sensitive than the FTA-CSF test. The use of undiluted CSF did not reduce the specificity of the MHA:TP test, as was shown by testing CSF samples from patients with diseases other than syphilis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045736Documentos Relacionados
- Evaluation of microhaemagglutination assay to determine treponemal antibodies in CSF.
- Further Evaluation of the Automated Fluorescent Treponemal Antibody Test for Syphilis
- Further studies of the fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test with a monospecific anti-IgM conjugate.
- Evaluation of the hemagglutination treponemal test for syphilis.
- A rostrocaudal gradient of nitrate plus nitrite concentrations in CSF.
